Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodger D MacArthur

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Expert Opinion on Pharmacotherapy|August 15, 2009
New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravirChristine A Hughes, Linda Robinson, Alice Tseng, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|December 10, 2002
Aerobic exercise training fails to lower hypertriglyceridemia levels in persons with advanced HIV-1 infectionThomas J Birk, Rodger D MacArthur, Lynn M Lipton, et al.
The American Journal of Case Reports|October 12, 2020
Widely Disseminated Cryptococcosis Manifesting in a Previously Undiagnosed Human Immunodeficiency Virus (HIV)-Positive 18-Year-OldJohn Howard, Thomas Z Thompson, Rodger D MacArthur, et al.
Journal of Clinical Microbiology|September 8, 2005
Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) Standard and ultrasensitive assays caused by freezing patient plasma in centrifuged becton-dickinson vacutainer brand plasma preparation tubesHossein Salimnia, Ellen C Moore, Lawrence R Crane, et al.
HIV Clinical Trials|March 6, 2004
A randomized clinical trial comparing nelfinavir and ritonavir in patients with advanced HIV disease (CPCRA 042/CTN 102)George Perez, Rodger D MacArthur, Sharon Walmsley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2003
Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trialRodger D MacArthur, Mark Miller, Timothy Albertson, et al.
HIV Clinical Trials|September 30, 2005
Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapyRodger D MacArthur, George Perez, Sharon Walmsley, et al.
AIDS Patient Care and Stds|May 5, 2010
Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trialThomas P Giordano, Glenn Bartsch, Yafeng Zhang, et al.
Antiviral Therapy|July 22, 2006
Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patientsMichael J Kozal, Katherine Huppler Hullsiek, Robert Leduc, et al.
IEEE Transactions on Systems, Man, and Cybernetics. Part B, Cybernetics : a Publication of the IEEE Systems, Man, and Cybernetics Society|August 19, 2007
A self-learning fuzzy discrete event system for HIV/AIDS treatment regimen selectionHao Ying, Feng Lin, Rodger D MacArthur, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Expert Opinion on Pharmacotherapy|August 15, 2009
New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravirChristine A Hughes, Linda Robinson, Alice Tseng, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|December 10, 2002
Aerobic exercise training fails to lower hypertriglyceridemia levels in persons with advanced HIV-1 infectionThomas J Birk, Rodger D MacArthur, Lynn M Lipton, et al.
The American Journal of Case Reports|October 12, 2020
Widely Disseminated Cryptococcosis Manifesting in a Previously Undiagnosed Human Immunodeficiency Virus (HIV)-Positive 18-Year-OldJohn Howard, Thomas Z Thompson, Rodger D MacArthur, et al.
Journal of Clinical Microbiology|September 8, 2005
Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) Standard and ultrasensitive assays caused by freezing patient plasma in centrifuged becton-dickinson vacutainer brand plasma preparation tubesHossein Salimnia, Ellen C Moore, Lawrence R Crane, et al.
HIV Clinical Trials|March 6, 2004
A randomized clinical trial comparing nelfinavir and ritonavir in patients with advanced HIV disease (CPCRA 042/CTN 102)George Perez, Rodger D MacArthur, Sharon Walmsley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 31, 2003
Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trialRodger D MacArthur, Mark Miller, Timothy Albertson, et al.
HIV Clinical Trials|September 30, 2005
Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapyRodger D MacArthur, George Perez, Sharon Walmsley, et al.
AIDS Patient Care and Stds|May 5, 2010
Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trialThomas P Giordano, Glenn Bartsch, Yafeng Zhang, et al.
Antiviral Therapy|July 22, 2006
Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patientsMichael J Kozal, Katherine Huppler Hullsiek, Robert Leduc, et al.
IEEE Transactions on Systems, Man, and Cybernetics. Part B, Cybernetics : a Publication of the IEEE Systems, Man, and Cybernetics Society|August 19, 2007
A self-learning fuzzy discrete event system for HIV/AIDS treatment regimen selectionHao Ying, Feng Lin, Rodger D MacArthur, et al.
Pageof 5